Company CVAbout Trident Lifeline Ltd 
Trident Lifeline Ltd
Micro Cap
Pharmaceuticals & Biotechnology
Trident Lifeline Limited was originally incorporated as Private Limited Company under the name "Trident Lifeline Private Limited" on January 09, 2014. Subsequently, Company converted into a Public Limited pursuant to Shareholders' Resolution on June 02, 2022 and name of Company was changed to "Trident Lifeline Limited" on June 10, 2022. The Company is engaged in business of marketing ethical pharmaceutical products in domestic as well as international market.
Company Coordinates
No Company Details Available
Capital StructureCapital Structure
Present Equity Capital
INR 11.50 Cr
Number of Shares
1.15 Cr
Face Value
INR 10.0
Date
Number
of Shares(Cr)
of Shares(Cr)
Equity
Capital (Rs Cr)
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
06-Oct-2022
1.15
11.50
3499200
10
Public Issue
04-Oct-2022
1.15
11.50
3499200
0
Public Issue
04-Oct-2022
1.15
11.50
3499200
10
Public Issue
01-Feb-2022
8
8.00
1500000
10
Preferential basis
09-Dec-2021
65
6.50
1500000
10
Preferential basis
17-Sep-2020
5
5.00
1900000
10
Preferential basis
11-Nov-2019
31
3.10
890000
10
Preferential basis
03-Mar-2019
22.1
2.21
1000000
10
Preferential basis
01-Dec-2016
12.1
1.21
1200000
10
Right Issues
09-Jan-2014
1
0.01
10000
10
Subscriber to MOA
ShareholdingShareholding Snapshot
Shareholding Compare (%holding)
Majority shareholders
Promoters
Pledged Promoter Holdings
3.4291
Mutual Funds
Held by 0 Schemes
FIIs
Held by 4 FIIs (7.71%)
Promoter with highest holding
Hardik Jigishkumar Desai (23.5%)
Highest Public shareholder
Nav Capital Vcc - Nav Capital Emerging Star Fund (6.01%)
Individual Investors Holdings
17.63%
Board of Directors
Management
Designation
Remuneration
Hardik J Desai
Chairman & Exec. Director
7.8 lacs
Mayurkumar Mansukhbhai Gajera
Whole Time Director & CFO
9.6 lacs
Shravan Harikrishna Patel
Managing Director
6.0 lacs
Maniya H Desai
Non Executive Director
9.78 lacs
Aena Surana
Independent Director
0
Mishal Shailesh Patel
Independent Director
0
Jiteshkumar Ramchandra Varkal
Company Sec. & Compli. Officer
0
Raw MaterialsRaw Materials Dashboard
Raw Materials
Amount(Rs Cr)
% of RM Cost
Raw Materials Consumed
24.1691
0%
Raw Materials Consumed
Finished Goods Finished Goods Dashboard
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
No Data Available for Finished Goods Segmentation
No Data Available
Stock DNARevenue and Profits:
Net Sales:
27 Cr
(Quarterly Results - Sep 2025)
Net Profit:
5 Cr
Pharmaceuticals & Biotechnology
INR 355 Cr (Micro Cap)
22.00
NA
0.00%
0.70
19.78%
4.39
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
